Protein Serine/Threonine phosphatase Polyclonal Antibody
The sirtuins are a gaggle of well-conserved proteins extensively distributed throughout all domains of life. These proteins are clustered within the class III of histone deacetylases and are distinctly characterised by their dependence upon NAD+ to hold out the deacetylation of lysine residues in histone proteins (H3 and H4) and non-histones such because the transcription issue p53.
The requirement of NAD+ for sirtuin exercise makes this group of proteins metabolic sensors, that are favored throughout caloric stress. At present, it’s recognized that these proteins are concerned in quite a few mobile processes which are elementary for the right functioning of cells, together with management of the cell cycle and mobile survival.
Despite the significance of sirtuins in cell capabilities, the function that these proteins play in protozoan parasites is just not fully understood.
On this examine, bioinformatic modeling and experimental characterization of the candidate G1Sir2.1 current within the genome of Giardia lamblia had been carried out. Consequently, cloning, expression, purification, and in vitro analysis of the recombinant GlSir2.1 protein’s capability for deacetylation had been carried out. This allowed for the identification of the NAD+-dependent deacetylase exercise of the recognized candidate. Manufacturing of anti-rHis-GlSir2.1 polyclonal antibodies enabled the remark of a cytoplasmic localization for the endogenous protein in trophozoites, which exhibited a perinuclear aggregation and co-localization with acetylated cytoskeleton buildings such because the flagella and median physique. At present, GlSir2.1 is the second sirtuin member of the family recognized in G. lambia, with a demonstrated cytoplasmic localization within the parasite.
Polyclonal Antibody
Research investigating serum midkine (s-MK) concentrations have employed a polyclonal antibody enzyme-linked immunosorbent assay system (ELISA), as a result of the focused polyclonal antibody has low specificity. We used a newly developed monoclonal antibody ELISA to research the prognostic and diagnostic capabilities of s-MK in sufferers with esophageal squamous cell carcinoma.
Serum samples from 102 sufferers with esophageal squamous cell carcinoma had been analyzed utilizing a newly developed monoclonal antibody ELISA particularly developed to detect s-MK. s-MK cutoff worth was set at 421 pg/mL (imply + 2 SD) based mostly on information from wholesome controls.
Clinicopathological traits, together with tumor stage and positivity charges for 2 standard tumor markers, serum p53 (s-p53-Abs) antibodies and SCC-antigen, had been evaluated to evaluate a potential correlation with s-MK. The prognostic functionality of a excessive s-MK stage was evaluated utilizing univariate and multivariate strategies.General optimistic charge for s-MK concentrations: 21%.
Giant tumors (> 50 mm) confirmed considerably increased concentrations than smaller specimens, however different clinicopathological elements weren’t related to s-MK. A mixture assay utilizing SCC-antigen along with s-p53-Abs and s-MK clearly elevated {our capability} to detect esophageal squamous cell carcinoma.
Protein Phosphatase 2A
Though the distinction was not statistically important (P = 0.310), the excessive s-MK group skilled worse general survival than our low s-MK group.s-MK and traditional tumor marker mixture elevated {our capability} to detect esophageal squamous cell carcinoma.
Though s-MK may be related to esophageal squamous cell carcinoma development, it was not an unbiased threat issue decreasing affected person survival. This examine was registered as UMIN000014530.
The thymus of outbred male rats 5 months after splenectomy (experimental secondary immunodeficiency) was studied by frequent histological and immunohistochemical strategies utilizing monoclonal and polyclonal antibodies to CD3, CD30, CD68, synaptophysin, to S100, p53, bcl-2, and Ki-67 proteins.
Alpha-bungarotoxin, CF640r |
|||
9-00004 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin, CF488a |
|||
9-00005 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-bungarotoxin CF488a |
|||
9-00005 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin, CF568 |
|||
9-00006 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-bungarotoxin, CF568 |
|||
9-00006 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin, CF594 |
|||
9-00007 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-bungarotoxin CF594 |
|||
9-00007 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin, CF633 |
|||
9-00009 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-bungarotoxin, CF633 |
|||
9-00009 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin |
|||
00010-1 | Biotium | 1MG | EUR 168 |
Description: Minimum order quantity: 1 unit of 1MG |
Fluorescein-Alpha-bungarotoxin |
|||
00011 | Biotium | 500uG | EUR 367 |
Description: Minimum order quantity: 1 unit of 500uG |
Tetramethylrhodamine-Alpha-bungarotoxin |
|||
00012 | Biotium | 500uG | EUR 383 |
Description: Minimum order quantity: 1 unit of 500uG |
Fluorescein-alpha-bungarotoxin: (10x50ug) |
|||
00013 | Biotium | 10ST | EUR 417 |
Description: Minimum order quantity: 1 unit of 10ST |
Tetramethylrhodamine-alpha-bungarotoxin: (10x50ug) |
|||
00014 | Biotium | 10ST | EUR 466 |
Description: Minimum order quantity: 1 unit of 10ST |
Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (500ug) |
|||
00015 | Biotium | 500uG | EUR 466 |
Description: Minimum order quantity: 1 unit of 500uG |
Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (10x50ug) |
|||
00016 | Biotium | 10ST | EUR 523 |
Description: Minimum order quantity: 1 unit of 10ST |
Biotin-xx-a-bungarotoxin |
|||
00017 | Biotium | 500uG | EUR 433 |
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-Bungarotoxin, CF555 conjugate |
|||
9-00018 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-Bungarotoxin, CF555 conjugate |
|||
9-00018 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100ug |
Biotin-cAMP, diisopropylethylammonium salt: |
|||
00020 | Biotium | 1MG | EUR 314 |
Description: Minimum order quantity: 1 unit of 1MG |
Biotin-cAMP, diisopropylethylammonium salt: (20x50ug) |
|||
00020-1 | Biotium | 20ST | EUR 418 |
Description: Minimum order quantity: 1 unit of 20ST |
Biotin-cGMP, diisopropylethylammonium salt: |
|||
00021 | Biotium | 1MG | EUR 344 |
Description: Minimum order quantity: 1 unit of 1MG |
Biotin-cGMP, diisopropylethylammonium salt: (20x50ug) |
|||
00021-1 | Biotium | 20ST | EUR 448 |
Description: Minimum order quantity: 1 unit of 20ST |
Cyanine 644-cAMP: |
|||
00022 | Biotium | 1MG | EUR 491 |
Description: Minimum order quantity: 1 unit of 1MG |
Cyanine 644-cAMP: (20x50ug) |
|||
00022-1 | Biotium | 20ST | EUR 625 |
Description: Minimum order quantity: 1 unit of 20ST |
Fluorescein Methotrexate, triammonium salt: |
|||
00023 | Biotium | 1MG | EUR 281 |
Description: Minimum order quantity: 1 unit of 1MG |
Staurosporine |
|||
00025 | Biotium | 100uG | EUR 139 |
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin, CF543 |
|||
00026 | Biotium | 500uG | EUR 494 |
Description: Minimum order quantity: 1 unit of 500uG |
Rhodamine phalloidin 300u |
|||
00027 | Biotium | 300 | EUR 345 |
Description: Minimum order quantity: 1 unit of 300 |
Biotin-xx-phalloidin |
|||
00028 | Biotium | 100U | EUR 428 |
Description: Minimum order quantity: 1 unit of 100U |
Fluorescein-phalloidin |
|||
00030 | Biotium | 300U | EUR 345 |
Description: Minimum order quantity: 1 unit of 300U |
Rhodamine 110 phalloidin |
|||
00032 | Biotium | 300ST | EUR 345 |
Description: Minimum order quantity: 1 unit of 300ST |
Sulforhodamine 101 (Texas-Red) Phalloidin |
|||
00033 | Biotium | 300EU | EUR 345 |
Description: Minimum order quantity: 1 unit of 300EU |
Phalloidin, CF405M |
|||
00034 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF405M |
|||
00034-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
CF488A-cAMP |
|||
00036 | Biotium | 100ug | EUR 172 |
Description: Minimum order quantity: 1 unit of 100ug |
CF640R-cAMP |
|||
00037 | Biotium | 100ug | EUR 172 |
Description: Minimum order quantity: 1 unit of 100ug |
Phalloidin, CF555 |
|||
00040 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF555 |
|||
00040-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF647 |
|||
00041 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF647 |
|||
00041-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF488A |
|||
00042 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF488A |
|||
00042-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF543 |
|||
00043 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF543 |
|||
00043-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF568 |
|||
00044 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF568 |
|||
00044-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF594 |
|||
00045 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF594 |
|||
00045-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF633 |
|||
00046 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF633 |
|||
00046-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF660R |
|||
00047 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF660R |
|||
00047-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF680R |
|||
00048 | Biotium | 300U | EUR 466 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF680R |
|||
00048-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF350 |
|||
00049 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF350 |
|||
00049-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF640R |
|||
00050 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF640R |
|||
00050-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF532 |
|||
00051 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF532 |
|||
00051-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF660C |
|||
00052 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF660C |
|||
00052-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF680 |
|||
00053 | Biotium | 300U | EUR 466 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF680 |
|||
00053-T | Biotium | 50U | EUR 147 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF430 |
|||
00054 | Biotium | 300U | EUR 449 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF430 |
|||
00054-T | Biotium | 50U | EUR 139 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF440 |
|||
00055 | Biotium | 300U | EUR 449 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF440 |
|||
00055-T | Biotium | 50U | EUR 139 |
Description: Minimum order quantity: 1 unit of 50U |
Cholera Toxin Subunit B, CF488A conjugate |
|||
00070 | Biotium | 100ug | EUR 261 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF568 conjugate |
|||
00071 | Biotium | 100ug | EUR 261 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF594 conjugate |
|||
00072 | Biotium | 100ug | EUR 261 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF640R conjugate |
|||
00073 | Biotium | 100ug | EUR 264 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF532 conjugate |
|||
00074 | Biotium | 100ug | EUR 264 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF543 conjugate |
|||
00075 | Biotium | 100ug | EUR 264 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF620R conjugate |
|||
00076 | Biotium | 100ug | EUR 264 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF633 conjugate |
|||
00077 | Biotium | 100ug | EUR 264 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF660R conjugate |
|||
00078 | Biotium | 100ug | EUR 264 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF680R conjugate |
|||
00079 | Biotium | 100ug | EUR 282 |
Description: Minimum order quantity: 1 unit of 100ug |
Human Transferrin, CF488A conjugate |
|||
00081 | Biotium | 1mg | EUR 149 |
Description: Minimum order quantity: 1 unit of 1mg |
Human Transferrin, CF543 conjugate |
|||
00082 | Biotium | 1mg | EUR 149 |
Description: Minimum order quantity: 1 unit of 1mg |
Human Transferrin, CF568 conjugate |
|||
00083 | Biotium | 1mg | EUR 149 |
Description: Minimum order quantity: 1 unit of 1mg |
Human Transferrin, CF594 conjugate |
|||
00084 | Biotium | 1mg | EUR 149 |
Description: Minimum order quantity: 1 unit of 1mg |
Human Transferrin, CF640R conjugate |
|||
00085 | Biotium | 1mg | EUR 149 |
Description: Minimum order quantity: 1 unit of 1mg |
Human Transferrin, CF680R conjugate |
|||
00086 | Biotium | 1mg | EUR 149 |
Description: Minimum order quantity: 1 unit of 1mg |
Human Transferrin, CF750 conjugate |
|||
00087 | Biotium | 1mg | EUR 155 |
Description: Minimum order quantity: 1 unit of 1mg |
HIV-1 tat recombinant antigen |
|||
00110-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV-1 tat recombinant antigen full length 15 kDa |
HIV-1 tat recombinant antigen |
|||
00110-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV-1 tat recombinant antigen full length 15 kDa |
HIV-1 GAG P24 Recombinant Antigen |
|||
00111-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV-1 GAG P24 Recombinant Antigen |
|||
00111-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV-1 nef recombinant antigen |
|||
00112-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa |
HIV-1 nef recombinant antigen |
|||
00112-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa |
HIV-1 env gp41 recombinant antigen |
|||
00113-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa |
HIV-1 env gp41 recombinant antigen |
|||
00113-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa |
HIV-2 GP 36 Recombinant Antigen |
|||
00114-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa |
HIV-2 GP 36 Recombinant Antigen |
|||
00114-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa |
HCV core recombinant antigen |
|||
00115-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa |
HCV core recombinant antigen |
|||
00115-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa |
HCV core recombinant antigen, Biotin conjugate |
|||
00115-V-B-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. |
HCV core recombinant antigen, Biotin conjugate |
|||
00115-V-B-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. |
HCV core recombinant antigen, FITC conjugate |
|||
00115-V-F-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate. |
HCV core recombinant antigen, FITC conjugate |
|||
00115-V-F-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate. |
HCV core recombinant antigen, Rhodamine |
|||
00115-V-R-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate. |
HCV core recombinant antigen, Rhodamine |
|||
00115-V-R-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate. |
HCV NS4 recombinant antigen NS4a+b |
|||
00116-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. |
HCV NS4 recombinant antigen NS4a+b |
|||
00116-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. |
HCV NS4 recombinant antigen NS4a+b, Biotin |
|||
00116-V-B-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate. |
HCV NS4 recombinant antigen NS4a+b, Biotin |
|||
00116-V-B-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate. |
HCV NS4 recombinant antigen NS4a+b, FITC |
|||
00116-V-F-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate. |
HCV NS4 recombinant antigen NS4a+b, FITC |
|||
00116-V-F-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate. |
HCV NS4 recombinant antigen NS4a+b, Rhodamine |
|||
00116-V-R-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate. |
HCV NS4 recombinant antigen NS4a+b, Rhodamine |
|||
00116-V-R-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate. |
HCV NS3 recombinant antigen |
|||
00117-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa |
HCV NS3 recombinant antigen |
|||
00117-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa |
HBV core recombinant antigen |
|||
00120-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 183 of HBV core antigen 18 kDa |
HBV core recombinant antigen |
|||
00120-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 183 of HBV core antigen 18 kDa |
HBV core recombinant antigen, Delta |
|||
00121-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa |
HBV core recombinant antigen, Delta |
|||
00121-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa |
HBV surface recombinant antigen HBsAg |
|||
00122-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant |
HBV surface recombinant antigen HBsAg |
|||
00122-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant |
HBV surface recombinant antigen HBsAg antigen |
|||
00123-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity |
HBV surface recombinant antigen HBsAg antigen |
|||
00123-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity |
HBV surface recombinant antigen HBsAg antigen |
|||
00124-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant |
HBV surface recombinant antigen HBsAg antigen |
|||
00124-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant |
HEV (Birma) ORF2 recombinant antigen |
|||
00131-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 633 to a.a 659. |
HEV (Birma) ORF2 recombinant antigen |
|||
00131-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 633 to a.a 659. |
HEV (Birma) ORF2 recombinant antigen |
|||
00132-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 403 to a.a 461. |
HEV (Birma) ORF2 recombinant antigen |
|||
00132-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 403 to a.a 461. |
AA 403-461 HEV Birma ORF2 Recombinant Antigen |
|||
00133-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 92 to a.a 123. |
AA 403-461 HEV Birma ORF2 Recombinant Antigen |
|||
00133-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 92 to a.a 123. |
T, Pallidum recombinant antigen p15 |
|||
00141-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: T. Pallidum recombinant antigen p15 (full length) |
T, Pallidum recombinant antigen p15 |
|||
00141-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: T. Pallidum recombinant antigen p15 (full length) |
T, Pallidum recombinant antigen p17 |
|||
00142-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: T. Pallidum recombinant antigen p17 (full length) |
T, Pallidum recombinant antigen p17 |
|||
00142-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: T. Pallidum recombinant antigen p17 (full length) |
T, Pallidum recombinant antigen p45 |
|||
00143-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: T. Pallidum recombinant antigen p45 (full length) |
T, Pallidum recombinant antigen p45 |
|||
00143-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: T. Pallidum recombinant antigen p45 (full length) |
T, pallidum recombinant antigen TmpA |
|||
00144-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: T. Pallidum recombinant antigen TmpA (full length) |
T, pallidum recombinant antigen TmpA |
|||
00144-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: T. Pallidum recombinant antigen TmpA (full length) |
HCV core 2-119aa recombinant antigen |
|||
00150-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a |
HCV core 2-119aa recombinant antigen |
|||
00150-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a |
HCV Core 24 Antigen |
|||
00151-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV core 24 antigen. |
HCV Core 24 Antigen |
|||
00151-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV core 24 antigen. |
HCV core recombinant antigen |
|||
00152-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV core recombinant antigen a.a.105-302 |
HCV core recombinant antigen |
|||
00152-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV core recombinant antigen a.a.105-302 |
HCV NS3 1192-1456 aa Recombinant Antigen |
|||
00153-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS3 1192-1456aa recombinant antigen a.a.1192-1459. Available genotypes: 1a, 1b, 2b, 2c, 5, 6a |
HCV NS3 1192-1456 aa Recombinant Antigen |
|||
00153-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS3 1192-1456aa recombinant antigen a.a.1192-1459. Available genotypes: 1a, 1b, 2b, 2c, 5, 6a |
HCV NS3 1359-1456aa antigen |
|||
00154-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS3 1359-1456aa antigen. The protein contains immunodominant regions (1359-1456aa). available genotypes: 1a, 1b, 2b, 3, 4, 5, 6 |
HCV NS3 1359-1456aa antigen |
|||
00154-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS3 1359-1456aa antigen. The protein contains immunodominant regions (1359-1456aa). available genotypes: 1a, 1b, 2b, 3, 4, 5, 6 |
HCV NS4 mosaic recombinant antigen |
|||
00155-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS4 mosaic recombinant antigen a.a1691-1710, 1712-1733, 1921-1940. Genotypes available: 1, 2, 3, 5. |
HCV NS4 mosaic recombinant antigen |
|||
00155-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS4 mosaic recombinant antigen a.a1691-1710, 1712-1733, 1921-1940. Genotypes available: 1, 2, 3, 5. |
HCV NS4 1916-1947aa recombinant antigen |
|||
00156-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS4 1916-1947aa recombinant antigen. |
HCV NS4 1916-1947aa recombinant antigen |
|||
00156-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS4 1916-1947aa recombinant antigen. |
HCV NS5 2061-2302aa recombinant antigen |
|||
00157-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS5 2061-2302aa recombinant antigen. |
HCV NS5 2061-2302aa recombinant antigen |
|||
00157-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS5 2061-2302aa recombinant antigen. |
HCV NS5 2212-2313aa recombinant antigen |
|||
00158-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS5 2212-2313aa recombinant antigen. Available genotypes: 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a. |
HCV NS5 2212-2313aa recombinant antigen |
|||
00158-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS5 2212-2313aa recombinant antigen. Available genotypes: 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a. |
HAV VP1-P2A recombinant antigen |
|||
00159-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HAV VP1-P2A recombinant antigen a.a. 722-830. |
HAV VP1-P2A recombinant antigen |
|||
00159-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HAV VP1-P2A recombinant antigen a.a. 722-830. |
HAV VP4-VP2 recombinant antigen |
|||
00160-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HAV VP4-VP2 recombinant antigen a.a. 55-164. |
HAV VP4-VP2 recombinant antigen |
|||
00160-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HAV VP4-VP2 recombinant antigen a.a. 55-164. |
HAV P2C-P3A recombinant antigen |
|||
00161-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HAV P2C-P3A recombinant antigen a.a. 1492-1606. |
HAV P2C-P3A recombinant antigen |
|||
00161-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HAV P2C-P3A recombinant antigen a.a. 1492-1606. |
HAV P3C recombinant antigen |
|||
00162-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HAV P3C recombinant antigen a.a. 1643-1743. |
HAV P3C recombinant antigen |
|||
00162-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HAV P3C recombinant antigen a.a. 1643-1743. |
HAV VP3 recombinant antigen |
|||
00163-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HAV VP3 recombinant antigen a.a. 304-415. |
HAV VP3 recombinant antigen |
|||
00163-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HAV VP3 recombinant antigen a.a. 304-415. |
HAV VP1-P2A recombinant antigen |
|||
00164-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HAV VP1-P2A recombinant antigen a.a. 669-782. |
HAV VP1-P2A recombinant antigen |
|||
00164-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HAV VP1-P2A recombinant antigen a.a. 669-782. |
HAV HAV P2C recombinant antigen |
|||
00165-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HAV HAV P2C recombinant antigen a.a. 1121-1234. |
HAV HAV P2C recombinant antigen |
|||
00165-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HAV HAV P2C recombinant antigen a.a. 1121-1234. |
HAV P2C-P3A recombinant antigen |
|||
00166-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HAV P2C-P3A recombinant antigen a.a. 1392-1521. |
HAV P2C-P3A recombinant antigen |
|||
00166-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HAV P2C-P3A recombinant antigen a.a. 1392-1521. |
HIV-1 p17/24/gp120-gp41 recombinant antigen, |
|||
00168-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV-1 p17/24/gp120-gp41 recombinant antigen. |
HIV-1 p17/24/gp120-gp41 recombinant antigen, |
|||
00168-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV-1 p17/24/gp120-gp41 recombinant antigen. |
HIV-1 p17/24/gp120 antigen |
|||
00169-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. |
HIV-1 p17/24/gp120 antigen |
|||
00169-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. |
HIV-1 gp41 recombinant antigen, |
|||
00170-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV-1 gp41 recombinant antigen. |
HIV-1 gp41 recombinant antigen, |
|||
00170-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV-1 gp41 recombinant antigen. |
HIV-1 gp41 Long recombinant antigen, |
|||
00171-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV-1 gp41 Long recombinant antigen. |
HIV-1 gp41 Long recombinant antigen, |
|||
00171-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV-1 gp41 Long recombinant antigen. |
HIV-2 gp32 recombinant antigen |
|||
00173-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV-2 gp32 recombinant antigen. . |
HIV-2 gp32 recombinant antigen |
|||
00173-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV-2 gp32 recombinant antigen. . |
HIV-1 p24 recombinant antigen, |
|||
00174-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV-1 p24 recombinant antigen. |
HIV-1 p24 recombinant antigen, |
|||
00174-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV-1 p24 recombinant antigen. |
HIV 1, 2 envelope recombinant antigen |
|||
00175-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV 1, 2 envelope recombinant antigen. HIV-1 envelope conjugated to HIV-2 envelope peptide. |
HIV 1, 2 envelope recombinant antigen |
|||
00175-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV 1, 2 envelope recombinant antigen. HIV-1 envelope conjugated to HIV-2 envelope peptide. |
HIV 1 envelope recombinant antigen |
|||
00176-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV 1 envelope recombinant antigen. HIV-1 evnelope protein spanning the C-Terminus of gp 120 and most of gp 41. |
HIV 1 envelope recombinant antigen |
|||
00176-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV 1 envelope recombinant antigen. HIV-1 evnelope protein spanning the C-Terminus of gp 120 and most of gp 41. |
HIV 1 p24 core recombinant antigen |
|||
00177-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV 1 p24 core recombinant antigen. |
HIV 1 p24 core recombinant antigen |
|||
00177-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV 1 p24 core recombinant antigen. |
HIV type O envelope antigen |
|||
00178-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV type O envelope antigen. Synthetic HIV type-O peptide, containing the HIV type-O envelope-derived sequence. |
HIV type O envelope antigen |
|||
00178-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV type O envelope antigen. Synthetic HIV type-O peptide, containing the HIV type-O envelope-derived sequence. |
HIV -2 env gp36 recombinant antigen |
|||
00179-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV -2 env gp36 recombinant antigen. a.a 390 to a.a 702. |
HIV -2 env gp36 recombinant antigen |
|||
00179-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV -2 env gp36 recombinant antigen. a.a 390 to a.a 702. |
HIV 2 gp36 envelope antigen |
|||
00180-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV 2 gp36 envelope antigen. Synthetic HIV-2 Peptide containing the HIV-2 specific sequence of gp36. |
HIV 2 gp36 envelope antigen |
|||
00180-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV 2 gp36 envelope antigen. Synthetic HIV-2 Peptide containing the HIV-2 specific sequence of gp36. |
HSV-1 gD recombinant antigen |
|||
00181-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HSV-1 gD recombinant antigen a.a. 266-394. |
HSV-1 gD recombinant antigen |
|||
00181-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HSV-1 gD recombinant antigen a.a. 266-394. |
HSV-2 gD recombinant antigen |
|||
00182-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HSV-2 gD recombinant antigen a.a. 266-394. |
HSV-2 gD recombinant antigen |
|||
00182-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HSV-2 gD recombinant antigen a.a. 266-394. |
Removing of the spleen led to acute involution of the thymic parenchyma, which was changed by the adipose tissue and was related to restructuring of the thymopoietic and nonthymopoietic elements of the gland, modifications in mobile composition and antigenic phenotype of the lobular cortical and medullary matter, and by discount of cell proliferation.